Related Experiment Video
Updated: Jun 12, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term
Robert D Sanders1, Helen J Manning, Nicola J Robertson
1Departments of Anaesthetics, Medical Research Council Clinical Sciences Centre, Queen Charlotte's & Chelsea Hospital, Imperial College London, London, United Kingdom.
Insights
Perinatal hypoxic-ischemic encephalopathy (HIE) is a severe childbirth complication. Reviewing neuroprotective strategies like hypothermia and preconditioning offers hope for reducing HIE
Area of Science:
- Neonatal neurology
- Perinatal medicine
- Neuroscience
Background:
- Perinatal hypoxic-ischemic encephalopathy (HIE) is a critical complication during childbirth.
- HIE can lead to severe neurological deficits in newborns.
- Current understanding focuses on mitigating brain injury through timely interventions.
Purpose of the Study:
- To review the pathophysiology of HIE.
- To evaluate current neuroprotective strategies for HIE.
- To explore advancements in monitoring, identification, and therapeutic interventions.
Main Methods:
- Literature review of pathophysiology and neuroprotection in HIE.
- Analysis of clinical trials on hypothermia therapy.
- Examination of preclinical evidence for adjunctive therapies and preconditioning.
Main Results:
- Hypothermia therapy shows significant benefit in the postnatal period for HIE.
- Preconditioning strategies may reduce brain vulnerability before HIE.
- Adjunctive therapies show promise in enhancing hypothermic neuroprotection.
Conclusions:
- Timely monitoring, identification, and post-insult therapies are crucial for managing HIE.
- Hypothermia is a proven neuroprotective strategy.
- Further research into preconditioning and adjunctive therapies holds promise for improved HIE outcomes.
Abstract:
Perinatal hypoxic-ischemic encephalopathy can be a devastating complication of childbirth. Herein, the authors review the pathophysiology of hypoxic-ischemic encephalopathy and the current status of neuroprotective strategies to ameliorate the injury centering on four themes: (1) monitoring in the perinatal period, (2) rapid identification of affected neonates to allow timely institution of therapy, (3) preconditioning therapy (a therapeutic that reduces the brain vulnerability) before hypoxic-ischemic encephalopathy, and (4) prompt institution of postinsult therapies to ameliorate the evolving injury. Recent clinical trials have demonstrated the significant benefit for hypothermic therapy in the postnatal period; furthermore, there is accumulating preclinical evidence that adjunctive therapies can enhance hypothermic neuroprotection. Advances in the understanding of preconditioning may lead to the administration of neuroprotective agents earlier during childbirth. Although most of these neuroprotective strategies have not yet entered clinical practice, there is a significant hope that further developments will enhance hypothermic neuroprotection.
